Gastarc
Description

Composition:
Each 5 ml contains Ranitidine HCl 84 mg equivalent to Ranitidine 75 mg.
Also contains non active ingredients: Sodium phosphate dibasic, Glycerin, Propylene glycol, Propylparaben, Methylparaben, Sodium phosphate monobasic, Saccharin sodium Spearmint flavor, Water.

Indications:

Reflux oesophagitis, benign gastric and duodenal ulceration, prophylaxis of stress ulceration, other

conditions where gastric acid reduction is beneficial Prophylaxis of NSAID-associated gastric ulcer /
Prophylaxis of NSAID-associated duodenal ulcer
benign gastric and duodenal ulceration
Chronic episodic dyspepsia
NSAID-associated gastric ulceration
NSAID-associated duodenal ulcer
Gastro-oesophageal reflux disease
Moderate to severe gastro-oesophageal reflux disease
Long-term treatment of healed gastro-oesophageal reflux disease
Gastric acid reduction (prophylaxis of acid aspiration) in obstetrics

image